Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. Other stock markets 15:35:31 18/06/2026 HKT			5-day change	1st Jan Change
2,234.00 ^INR	+1.60%		+6.24%	-9.59%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	372,498	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	-3.7%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	372,498	372,498
Change	-	-18.99%	58.51%	48.08%	-20.64%	-3.7%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	32.7x	28.9x
PBR	10.6x	12.9x	18.5x	25x	17.1x	14x	11.9x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.3x	2.2x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	8.88x	8.02x
EV / Revenue	0x	0x	0x	0x	0x	8.88x	8.02x
EV / EBITDA	0x	0x	0x	0x	0x	25.4x	22.3x
EV / EBIT	0x	0x	0x	0x	0x	27.1x	23.7x
EV / FCF	0x	0x	0x	0x	0x	32.1x	29x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	3.11%	3.45%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.34%	1.34%
EPS ²	100	36.05	34.83	54.76	61.15	67.3	75.97
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.8%	38.8%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,939	46,453
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,683	16,675
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,402	12,873
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,198.85	2,198.85
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	16/5/22	17/5/23	17/5/24	13/5/25	13/5/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	32.67x	-	-	1.34%	3.95B
ELI LILLY AND COMPANY	32.54x	11.83x	24.36x	0.61%	992B
JOHNSON & JOHNSON	25.03x	5.77x	15.69x	2.28%	564B
ABBVIE INC.	27.45x	6.62x	13.53x	3.1%	391B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	330B
ASTRAZENECA PLC	22.62x	4.72x	13.39x	1.85%	280B
NOVARTIS AG	21.12x	5.46x	13.25x	2.94%	279B
NOVO NORDISK A/S	12.67x	4.72x	9.72x	3.98%	196B
AMGEN INC.	22.21x	5.97x	10.43x	2.95%	184B
GILEAD SCIENCES, INC.	-44.95x	5.42x	29.92x	2.59%	156B
Average	16.88x	6.10x	15.66x	2.47%	337.52B
Weighted average by Cap.	22.16x	7.33x	17.13x	2.13%